市場調查報告書
商品編碼
1055307

全球血管閉合裝置 (VCD) 市場:COVID-19 的增長、趨勢、影響和預測(2022-2027 年)

Vascular Closure Device (VCD) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球血管閉合裝置 (VCD) 市場規模預計在預測期內的複合年增長率為 5.67%。

推動市場增長的主要因素是股心導管術的廣泛使用、VCD 提高患者舒適度的高成功率、止血時間的縮短以及 VCD 克服併發症的功能等。

本報告探討了全球血管閉合器 (VCD) 市場,包括市場概況、市場增長和製約因素分析、產品類型、訪問方式、最終用戶和區域分析。它提供了競爭性等綜合信息主要公司的情況和概況。

目錄

第一章介紹

第二章調查方法

第 3 章執行摘要

第四章市場動態

  • 市場概況
  • 市場促進因素
    • 導管相關手術增加
    • 對微創解決方案的需求增加
    • VCD 易於使用
  • 市場製約因素
    • 產品成本高
    • VCD 相關併發症
  • 波特五力分析

第 5 章市場細分

  • 產品類型
    • 主動式測距儀
    • 被動式近距儀
  • 訪問方式
    • 股動脈
    • 橈動脈
  • 最終用戶
    • 醫院
    • 門診手術中心
    • 其他
  • 地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東和非洲
    • 南美洲

第6章競爭態勢

  • 公司簡介
    • Abbott Laboratories
    • Advanced Vascular Dynamics
    • B. Braun Melsungen AG
    • Biotronik SE &Co. KG
    • CR Bard Inc.
    • Cardinal Health Inc.
    • Cardiva Medical Inc.
    • Scion Biomedicals Inc.
    • St. Jude Medical
    • Terumo Corporation

第7章 市場機會動向

目錄
Product Code: 66042

The Global vascular closure device (VCD) market is anticipated to exhibit a CAGR of 5.67% over the forecast period. Growing popularity of femoral artery cardiac catheterization, high success rate of VCDs for improved patient comfort, and shortening of hemostasis time are potential factors for the projected growth of VCDs market over the forecast period. Adoption of VCDs for diagnostic and therapeutic interventions that facilitate endovascular image-guided interventions to detect coronary heart disease are expected to contribute toward the growth of this market throughout the forecast period.

Moreover, ability of VCDs to overcome complications, such as prolonged bed rest and patient discomfort caused by manual compression, is expected to revolutionize the market growth over the forecast period.

Key Market Trends

Active Approximators led the Product Type segment in 2018

The global VCD market has been segmented on the basis of product type into Active Approximators and Passive Approximators. The active approximator segment is further sub-segmented into clips, suture mediated devices, and plugs while the passive approximator segment is further sub-segmented into hemostatic pads/patches and compression devices. In 2018 the active approximators segment led the product type segment of the market as they shorten the time to ambulation and possess high efficiency rate compared to manual compression.

North America has the largest share in global VCD market

Region wise North America is the largest market, followed by Europe and Asia Pacific. The North America regions has an array of opportunities for growth which is attracting new investors in the vascular closure market. Growth is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.

Additionally, the North America region is expected to exhibit highest growth rate over the forecast period primarily due to increasing catheterization related procedures (PCI), preference for minimally-invasive solutions & rise in vascular procedures. Ease in usage and quick hemostatic properties of VCDs and increased utilization of transradial arterial access.

However, in the developing regions of South America and Asia Pacific, factors like high price of products, complications associated with VCD, lower adoption rates of novel technologies are hampering the market of vascular closure device.

Competitive Landscape

This market is expected to witness lucrative growth owing to high level of competitive rivalry, which translates to high revenue generation in this sector. The prominent players in this market are involved in developing novel VCDs and in turn broaden their product portfolios. Acquisition and collaboration with small companies in order to enhance presence is also expected to propel growth in this vertical.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increase in Catheterization Related Procedures
    • 4.2.2 Increase in Demand For Minimally-Invasive Solutions
    • 4.2.3 Ease of Usage of VCDs
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Products
    • 4.3.2 Complications Associated with VCDs
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Product Type
    • 5.1.1 Active Approximators
      • 5.1.1.1 Clip Based Devices
      • 5.1.1.2 Suture Based Devices
      • 5.1.1.3 Plug Based Devices
    • 5.1.2 Passive Approximators
      • 5.1.2.1 Hemostatic Pads & Patches
      • 5.1.2.2 Compression Devices
  • 5.2 Mode of Access
    • 5.2.1 Femoral Access
    • 5.2.2 Radial Access
  • 5.3 End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centres
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Advanced Vascular Dynamics
    • 6.1.3 B. Braun Melsungen AG
    • 6.1.4 Biotronik SE & Co. KG
    • 6.1.5 C.R. Bard Inc.
    • 6.1.6 Cardinal Health Inc.
    • 6.1.7 Cardiva Medical Inc.
    • 6.1.8 Scion Biomedicals Inc.
    • 6.1.9 St. Jude Medical
    • 6.1.10 Terumo Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS